Knock-out of dipeptidase CN2 in human proximal tubular cells disrupts dipeptide and amino acid homeostasis and para- and transcellular solute transport.

amino acids dipeptidase glutathione ion transport proliferation proximal tubule

Journal

Acta physiologica (Oxford, England)
ISSN: 1748-1716
Titre abrégé: Acta Physiol (Oxf)
Pays: England
ID NLM: 101262545

Informations de publication

Date de publication:
22 Mar 2024
Historique:
revised: 15 02 2024
received: 24 08 2023
accepted: 21 02 2024
medline: 22 3 2024
pubmed: 22 3 2024
entrez: 22 3 2024
Statut: aheadofprint

Résumé

Although of potential biomedical relevance, dipeptide metabolism has hardly been studied. We found the dipeptidase carnosinase-2 (CN2) to be abundant in human proximal tubules, which regulate water and solute homeostasis. We therefore hypothesized, that CN2 has a key metabolic role, impacting proximal tubular transport function. A knockout of the CN2 gene (CNDP2-KO) was generated in human proximal tubule cells and characterized by metabolomics, RNA-seq analysis, paracellular permeability analysis and ion transport. CNDP2-KO in human proximal tubule cells resulted in the accumulation of cellular dipeptides, reduction of amino acids and imbalance of related metabolic pathways, and of energy supply. RNA-seq analyses indicated altered protein metabolism and ion transport. Detailed functional studies demonstrated lower CNDP2-KO cell viability and proliferation, and altered ion and macromolecule transport via trans- and paracellular pathways. Regulatory and transport protein abundance was disturbed, either as a consequence of the metabolic imbalance or the resulting functional disequilibrium. CN2 function has a major impact on intracellular amino acid and dipeptide metabolism and is essential for key metabolic and regulatory functions of proximal tubular cells. These findings deserve in vivo analysis of the relevance of CN2 for nephron function and regulation of body homeostasis.

Identifiants

pubmed: 38517248
doi: 10.1111/apha.14126
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e14126

Subventions

Organisme : Elite Programme
Organisme : Olympia Morata Program of Heidelberg University
Organisme : Deutsche Forschungsgemeinschaft

Informations de copyright

© 2024 The Authors. Acta Physiologica published by John Wiley & Sons Ltd on behalf of Scandinavian Physiological Society.

Références

Bartosova M, Herzog R, Ridinger D, et al. Alanyl‐glutamine restores tight junction organization after disruption by a conventional peritoneal dialysis fluid. Biomolecules. 2020;10(8):1178.
Moreno JC, Rojas BE, Vicente R, et al. Tyr‐asp inhibition of glyceraldehyde 3‐phosphate dehydrogenase affects plant redox metabolism. EMBO J. 2021;40:e106800.
Boldyrev AA, Aldini G, Derave W. Physiology and pathophysiology of carnosine. Physiol Rev. 2013;93(4):1803‐1845.
Weigand T, Colbatzky F, Pfeffer T, et al. A global Cndp1‐Knock‐out selectively increases renal carnosine and anserine concentrations in an age‐ and gender‐specific manner in mice. Int J Mol Sci. 2020;21(14):4887.
Kaur H, Kumar C, Junot C, Toledano MB, Bachhawat AK. Dug1p is a Cys‐Gly peptidase of the gamma‐glutamyl cycle of Saccharomyces cerevisiae and represents a novel family of Cys‐Gly peptidases. J Biol Chem. 2009;284(21):14493‐14502.
Kobayashi S, Homma T, Okumura N, et al. Carnosine dipeptidase II (CNDP2) protects cells under cysteine insufficiency by hydrolyzing glutathione‐related peptides. Free Radic Biol Med. 2021;174:12‐27.
Kim JT, Li VL, Terrell SM, Fischer CR, Long JZ. Family‐wide annotation of enzymatic pathways by parallel in vivo metabolomics. Cell Chem Biol. 2019;26(11):1623‐1629.e3.
Jansen RS, Addie R, Merkx R, et al. N‐lactoyl‐amino acids are ubiquitous metabolites that originate from CNDP2‐mediated reverse proteolysis of lactate and amino acids. Proc Natl Acad Sci USA. 2015;112(21):6601‐6606.
Li VL, He Y, Contrepois K, et al. An exercise‐inducible metabolite that suppresses feeding and obesity. Nature. 2022;606(7915):785‐790.
Ahluwalia TS, Lindholm E, Groop LC. Common variants in CNDP1 and CNDP2, and risk of nephropathy in type 2 diabetes. Diabetologia. 2011;54(9):2295‐2302.
McDonough C, Hicks PJ, Lu L, Langefeld CD, Freedman BI, Bowden DW. The influence of carnosinase gene polymorphisms on diabetic nephropathy risk in African‐Americans. Hum Genet. 2009;126:265‐275.
Di Meo A, Batruch I, Brown MD, et al. Searching for prognostic biomarkers for small renal masses in the urinary proteome. Int J Cancer. 2020;146(8):2315‐2325.
Vu HM, Mohammad HB, Nguyen TNC, et al. Quantitative proteomic analysis of bronchoalveolar lavage fluids from patients with small cell lung cancers. Proteomics Clin Appl. 2023;17:e2300011.
Zhang LQ, Yang HQ, Yang SQ, et al. CNDP2 acts as an activator for human ovarian cancer growth and metastasis via the PI3K/AKT pathway. Technol Cancer Res Treat. 2019;18:1533033819874773.
Speed JS, Fox BM, Johnston JG, Pollock DM. Endothelin and renal ion and water transport. Semin Nephrol. 2015;35(2):137‐144.
van de Poll MC, Soeters PB, Deutz NE, Fearon KC, Dejong CH. Renal metabolism of amino acids: its role in interorgan amino acid exchange. Am J Clin Nutr. 2004;79(2):185‐197.
Nakamura M, Satoh N, Horita S, Nangaku M. Insulin‐induced mTOR signaling and gluconeogenesis in renal proximal tubules: a mini‐review of current evidence and therapeutic potential. Front Pharmacol. 2022;13:1015204.
Li H, Dai W, Liu Z, He L. Renal proximal tubular cells: a new site for targeted delivery therapy of diabetic kidney disease. 2022;15(12):1494.
Mohandes S, Doke T, Hu H, Mukhi D, Dhillon P, Susztak K. Molecular pathways that drive diabetic kidney disease. J Clin Invest. 2023;133(4):e165654.
Garibotto G, Tessari P, Sacco P, Deferrari G. Amino acid metabolism, substrate availability and the control of protein dynamics in the human kidney. J Nephrol. 1999;12(4):203‐211.
Nowak KL, Hopp K. Metabolic reprogramming in autosomal dominant polycystic kidney disease: evidence and therapeutic potential. Clin J Am Soc Nephrol. 2020;15(4):577‐584.
Asghari G, Teymoori F, Farhadnejad H, Mirmiran P, Azizi F. Dietary amino acid patterns are associated with incidence of chronic kidney disease. J Ren Nutr. 2022;32(3):312‐318.
Butler M, van der Meer LT, van Leeuwen FN. Amino acid depletion therapies: starving cancer cells to death. Trends Endocrinol Metab. 2021;32(6):367‐381.
Pfeffer T, Wetzel C, Kirschner P, et al. Carnosinase‐1 Knock‐out reduces kidney fibrosis in Type‐1 diabetic mice on high fat diet. Antioxidants (Basel, Switzerland). 2023;12(6):1270.
Peters V, Schmitt CP, Weigand T, et al. Allosteric inhibition of carnosinase (CN1) by inducing a conformational shift. J Enzyme Inhib Med Chem. 2017;32(1):1102‐1110.
Peters V, Klessens CQ, Baelde HJ, et al. Intrinsic carnosine metabolism in the human kidney. Amino Acids. 2015;47:2541‐2550.
Lazareth H, Lenoir O, Tharaux PL. Parietal epithelial cells role in repair versus scarring after glomerular injury. Curr Opin Nephrol Hypertens. 2020;29(3):293‐301.
Heidenreich E, Pfeffer T, Kracke T, et al. A novel UPLC‐MS/MS method identifies organ‐specific dipeptide profiles. Int J Mol Sci. 2021;22(18):9979.
Kandasamy P, Gyimesi G, Kanai Y, Hediger MA. Amino acid transporters revisited: new views in health and disease. Trends Biochem Sci. 2018;43(10):752‐789.
Valdivielso JM, Eritja À, Caus M, Bozic M. Glutamate‐gated NMDA receptors: insights into the function and signaling in the kidney. Biomolecules. 2020;10(7):1051.
Jappar D, Hu Y, Keep RF, Smith DE. Transport mechanisms of carnosine in SKPT cells: contribution of apical and basolateral membrane transporters. Pharm Res. 2009;26(1):172‐181.
Alghamdi OA, King N, Jones GL, Moens PDJ. Kinetic measurements of Di‐ and tripeptide and peptidomimetic drug transport in different kidney regions using the fluorescent membrane potential‐sensitive dye, DiS‐C(3)‐(3). J Membr Biol. 2017;250(6):641‐649.
Smith DE, Clémençon B, Hediger MA. Proton‐coupled oligopeptide transporter family SLC15: physiological, pharmacological and pathological implications. Mol Asp Med. 2013;34(2–3):323‐336.
Makrides V, Camargo SM, Verrey F. Transport of amino acids in the kidney. Compr Physiol. 2014;4(1):367‐403.
Zietek T, Giesbertz P, Ewers M, et al. Organoids to study intestinal nutrient transport, drug uptake and metabolism ‐ update to the human model and expansion of applications. Front Bioeng Biotechnol. 2020;8:577656.
Long KR, Rbaibi Y, Bondi CD, et al. Cubilin‐, megalin‐, and Dab2‐dependent transcription revealed by CRISPR/Cas9 knockout in kidney proximal tubule cells. Am J Physiol Renal Physiol. 2022;322(1):F14‐F26.
Li X, Zheng S, Wu G. Amino acid metabolism in the kidneys: nutritional and physiological significance. Adv Exp Med Biol. 2020;1265:71‐95.
Marini HR, Facchini BA, di Francia R, et al. Glutathione: lights and shadows in cancer patients. Biomedicine. 2023;11(8):2226.
Chen TK, Knicely DH, Grams ME. Chronic kidney disease diagnosis and management: a review. JAMA. 2019;322(13):1294‐1304.
Fromm M, Piontek J, Rosenthal R, Günzel D, Krug SM. Tight junctions of the proximal tubule and their channel proteins. Pflugers Arch. 2017;469(7–8):877‐887.
Furuse M, Hata M, Furuse K, et al. Claudin‐based tight junctions are crucial for the mammalian epidermal barrier: a lesson from claudin‐1‐deficient mice. J Cell Biol. 2002;156(6):1099‐1111.
Milatz S, Krug SM, Rosenthal R, et al. Claudin‐3 acts as a sealing component of the tight junction for ions of either charge and uncharged solutes. Biochim Biophys Acta. 2010;1798(11):2048‐2057.
Amasheh S, Meiri N, Gitter AH, et al. Claudin‐2 expression induces cation‐selective channels in tight junctions of epithelial cells. J Cell Sci. 2002;115(Pt 24):4969‐4976.
Yu AS, Enck AH, Lencer WI, Schneeberger EE. Claudin‐8 expression in Madin‐Darby canine kidney cells augments the paracellular barrier to cation permeation. J Biol Chem. 2003;278(19):17350‐17359.
Angelow S, Kim KJ, Yu AS. Claudin‐8 modulates paracellular permeability to acidic and basic ions in MDCK II cells. J Physiol. 2006;571(Pt 1):15‐26.
Chmiel TA, Gardel ML. Confluence and tight junction dependence of volume regulation in epithelial tissue. Mol Biol Cell. 2022;33(11):ar98.
Haas AJ, Zihni C, Krug SM, et al. ZO‐1 guides tight junction assembly and epithelial morphogenesis via cytoskeletal tension‐dependent and ‐independent functions. Cells. 2022;11(23):3775.
Nayak B, Xie P, Akagi S, et al. Modulation of renal‐specific oxidoreductase/myo‐inositol oxygenase by high‐glucose ambience. Proc Natl Acad Sci USA. 2005;102(50):17952‐17957.
Prabhu KS, Arner RJ, Vunta H, Reddy CC. Up‐regulation of human myo‐inositol oxygenase by hyperosmotic stress in renal proximal tubular epithelial cells. J Biol Chem. 2005;280(20):19895‐19901.
Spires D, Manis AD, Staruschenko A. Ion channels and transporters in diabetic kidney disease. Curr Top Membr. 2019;83:353‐396.
Edwards JC. Chloride transport. Compr Physiol. 2012;2(2):1061‐1092.
Ran FA, Hsu PD, Wright J, Agarwala V, Scott DA, Zhang F. Genome engineering using the CRISPR‐Cas9 system. Nat Protoc. 2013;8(11):2281‐2308.
Teufel M, Saudek V, Ledig JP, et al. Sequence identification and characterization of human carnosinase and a closely related non‐specific dipeptidase. J Biol Chem. 2003;278(8):6251‐6531.
Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA‐seq data with DESeq2. Genome Biol. 2014;15(12):550.
Weger BD, Weger M, Gorling B, et al. Extensive regulation of diurnal transcription and metabolism by glucocorticoids. PLoS Genet. 2016;12(12):e1006512.
Fiskerstrand T, Refsum H, Kvalheim G, Ueland PM. Homocysteine and other thiols in plasma and urine: automated determination and sample stability. Clin Chem. 1993;39(2):263‐271.
Andresen C, Boch T, Gegner HM, et al. Comparison of extraction methods for intracellular metabolomics of human tissues. Front Mol Biosci. 2022;9:932261.
Bartosova M, Ridinger D, Marinovic I, et al. An experimental workflow for studying barrier integrity, permeability, and tight junction composition and localization in a single endothelial cell monolayer: proof of concept. Int J Mol Sci. 2021;22(15):8178.
Masereel B, Pochet L, Laeckmann D. An overview of inhibitors of Na(+)/H(+) exchanger. Eur J Med Chem. 2003;38(6):547‐554.
Günzel D, Amasheh S, Pfaffenbach S, et al. Claudin‐16 affects transcellular Cl‐ secretion in MDCK cells. J Physiol. 2009;587(Pt 15):3777‐3793.
Yu AS, Cheng MH, Angelow S, et al. Molecular basis for cation selectivity in claudin‐2‐based paracellular pores: identification of an electrostatic interaction site. J Gen Physiol. 2009;133(1):111‐127.
Schindelin J, Arganda‐Carreras I, Frise E, et al. Fiji: an open‐source platform for biological‐image analysis. Nat Methods. 2012;9(7):676‐682.

Auteurs

Tilman Pfeffer (T)

Medical Faculty Heidelberg, Center for Pediatric and Adolescent Medicine, Department I, Division of Pediatric Neurology and Metabolic Medicine, Heidelberg University, Heidelberg, Germany.
Tissue Bank of the German Center for Infection Research (DZIF), Partner Site Heidelberg, Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.

Susanne M Krug (SM)

Clinical Physiology/Nutritional Medicine, Charité-Universitätsmedizin Berlin, CBF, Berlin, Germany.

Tamara Kracke (T)

Medical Faculty Heidelberg, Center for Pediatric and Adolescent Medicine, Department I, Division of Pediatric Neurology and Metabolic Medicine, Heidelberg University, Heidelberg, Germany.

Robin Schürfeld (R)

Medical Faculty Heidelberg, Center for Pediatric and Adolescent Medicine, Department I, Division of Pediatric Neurology and Metabolic Medicine, Heidelberg University, Heidelberg, Germany.

Florian Colbatzky (F)

Medical Faculty Heidelberg, Center for Pediatric and Adolescent Medicine, Department I, Division of Pediatric Neurology and Metabolic Medicine, Heidelberg University, Heidelberg, Germany.

Philip Kirschner (P)

Medical Faculty Heidelberg, Center for Pediatric and Adolescent Medicine, Department I, Division of Pediatric Neurology and Metabolic Medicine, Heidelberg University, Heidelberg, Germany.

Rebekka Medert (R)

Institute of Pharmacology, Heidelberg University, Heidelberg, Germany.

Marc Freichel (M)

Institute of Pharmacology, Heidelberg University, Heidelberg, Germany.

Dagmar Schumacher (D)

Institute of Pharmacology, Heidelberg University, Heidelberg, Germany.

Maria Bartosova (M)

Medical Faculty Heidelberg, Center for Pediatric and Adolescent Medicine, Department I, Division of Pediatric Neurology and Metabolic Medicine, Heidelberg University, Heidelberg, Germany.

Sotiris G Zarogiannis (SG)

Medical Faculty Heidelberg, Center for Pediatric and Adolescent Medicine, Department I, Division of Pediatric Neurology and Metabolic Medicine, Heidelberg University, Heidelberg, Germany.

Martina U Muckenthaler (MU)

Department of Pediatric Oncology, Hematology and Immunology and Hopp Children Cancer Center (KiTZ), University Hospital Heidelberg, Heidelberg, Germany.
Molecular Medicine Partnership Unit (MMPU), EMBL and University of Heidelberg, Heidelberg, Germany.
Translational Lung Research Center Heidelberg (TLRC), German Center for Lung Research (DZL), University of Heidelberg, Heidelberg, Germany.
DZHK (German Centre for Cardiovascular Research), Partner Site Heidelberg/Mannheim, Heidelberg, Germany.

Sandro Altamura (S)

Department of Pediatric Oncology, Hematology and Immunology and Hopp Children Cancer Center (KiTZ), University Hospital Heidelberg, Heidelberg, Germany.
Molecular Medicine Partnership Unit (MMPU), EMBL and University of Heidelberg, Heidelberg, Germany.

Silvia Pezer (S)

Medical Faculty Heidelberg, Center for Pediatric and Adolescent Medicine, Department I, Division of Pediatric Neurology and Metabolic Medicine, Heidelberg University, Heidelberg, Germany.

Nadine Volk (N)

Tissue Bank of the National Center for Tumor Diseases (NCT), Heidelberg, Germany.

Constantin Schwab (C)

Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.

Stefan Duensing (S)

Department of Urology, University Hospital Heidelberg and National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg, Germany.

Thomas Fleming (T)

Internal Medicine I and Clinical Chemistry, University Hospital Heidelberg, Heidelberg, Germany.

Elena Heidenreich (E)

Centre for Organismal Studies (COS), University of Heidelberg, Heidelberg, Germany.

Johannes Zschocke (J)

Institute of Human Genetics, Medical University of Innsbruck, Innsbruck, Austria.

Rüdiger Hell (R)

Centre for Organismal Studies (COS), University of Heidelberg, Heidelberg, Germany.

Gernot Poschet (G)

Centre for Organismal Studies (COS), University of Heidelberg, Heidelberg, Germany.

Claus P Schmitt (CP)

Medical Faculty Heidelberg, Center for Pediatric and Adolescent Medicine, Department I, Division of Pediatric Neurology and Metabolic Medicine, Heidelberg University, Heidelberg, Germany.

Verena Peters (V)

Medical Faculty Heidelberg, Center for Pediatric and Adolescent Medicine, Department I, Division of Pediatric Neurology and Metabolic Medicine, Heidelberg University, Heidelberg, Germany.

Classifications MeSH